Kevin Doody, INVO BioScience, Inc.'s Medical Director and a director of the company, recently acquired 8,184 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on December 31, 2020. Doody now owns 169,821 shares of the company. Doody operates out of Sarasota, FL. Some additional info was provided as follows:
The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e- mail notification whenever INVO BioScience, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Notice of Effectiveness - April 16, 2021
Current report, items 1.01, 8.01, and 9.01 - April 13, 2021
Registration statement under Securities Act of 1933 - April 7, 2021
Invo Bioscience Reports 2020 Financial Results - March 30, 2021